>
Switch to:

BridgeBio Pharma Debt-to-Asset

: 0.61 As of Sep. 2020
View and export this data going back to 2019. Start your Free Trial

BridgeBio Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2020 was $3.62 Mil. BridgeBio Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2020 was $480.13 Mil. BridgeBio Pharma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2020 was $787.69 Mil. BridgeBio Pharma's debt to asset for the quarter that ended in Sep. 2020 was 0.61.


BridgeBio Pharma Debt-to-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19
Debt-to-Asset 0.00 0.00 0.15

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Debt-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.15 0.00 0.00 0.61

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


BridgeBio Pharma Debt-to-Asset Distribution

* The bar in red indicates where BridgeBio Pharma's Debt-to-Asset falls into.



BridgeBio Pharma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BridgeBio Pharma's Debt-to-Asset for the fiscal year that ended in Dec. 2019 is calculated as

BridgeBio Pharma's Debt-to-Asset for the quarter that ended in Sep. 2020 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3.617 + 480.13) / 787.693
=0.61

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


BridgeBio Pharma  (NAS:BBIO) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


BridgeBio Pharma Debt-to-Asset Related Terms


BridgeBio Pharma Debt-to-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)